Viability testing during normothermic machine perfusion requires both hepatocellular and cholangiocellular criteria

Updates Surg. 2021 Apr;73(2):781-783. doi: 10.1007/s13304-021-00976-x. Epub 2021 Jan 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Hepatocellular*
  • Humans
  • Liver Neoplasms*
  • Organ Preservation
  • Perfusion